Dr. Jonathan A. Polikoff, MD

Dr. Polikoff practices at Kaiser Permanente San Diego Medical Center in San Diego, California.

Dr. Polikoff's NPI, 1497822332, was assigned on November 29, 2006. Dr. Polikoff graduated from Albany Medical College of Union University in 1977. Dr. Polikoff holds Washington license MD61107981.

Dr. Polikoff's primary practice is Kaiser Permanente San Diego Medical Center, at 9455 Clairemont Mesa Blvd, San Diego, CA 92123 in San Diego County. The practice phone is (619) 528-5000.

Dr. Polikoff's primary practice is Kaiser Permanente San Diego Medical Center in San Diego, California. Dr. Polikoff is also affiliated with Kaiser Permanente Zion Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Polikoff to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Polikoff practices. Vendor and product names are available with a free account.

Medical oncology is Dr. Polikoff's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Polikoff's licenses on file in 2 states: Washington and California.

CMS data shows 11 Medicare services from Dr. Polikoff across 1 procedure code in 2022, all of them office visits. Medicare paid $594 for them. Every service was in a facility, such as a hospital, rather than an office.

Across all payers, Dmand AI patient panel data puts Dr. Polikoff's median patient age at 61, with 61% women.

In 2024, Dr. Polikoff wrote 76 Medicare Part D claims for 43 patients. 75% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $562 in total drug cost. In 2020, CMS named 23 claims across 2 drugs.

Dr. Polikoff accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Polikoff, published from 2010 to 2022. 2013 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Lenalidomide. Dr. Polikoff has published most often in Ann Oncol. Dr. Polikoff's most frequent co-authors are Eleftherios P. Mamounas, MD, Norman Wolmark, MD and James Norman Atkins, MD.

Dmand AI links Dr. Polikoff to 10 clinical trials, 3 of them phase 2 studies. 8 are still active or recruiting. Conditions studied include Breast Carcinoma In Situ, Breast Neoplasms and Carcinoma, Endometrioid. National Cancer Institute (NCI) sponsors the most, 6.

CMS Open Payments shows 41 general payments to Dr. Polikoff from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 37% of the total. Genentech, Inc. paid the most, $6,501. It also lists 3 research payments totaling $1,689 from 2016 to 2021.

Dr. Polikoff graduated from Albany Medical College of Union University in 1977.